Markku Hakala

4.9k total citations
102 papers, 2.9k citations indexed

About

Markku Hakala is a scholar working on Rheumatology, Surgery and Hematology. According to data from OpenAlex, Markku Hakala has authored 102 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Rheumatology, 21 papers in Surgery and 19 papers in Hematology. Recurrent topics in Markku Hakala's work include Rheumatoid Arthritis Research and Therapies (54 papers), Systemic Lupus Erythematosus Research (20 papers) and Autoimmune and Inflammatory Disorders Research (18 papers). Markku Hakala is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (54 papers), Systemic Lupus Erythematosus Research (20 papers) and Autoimmune and Inflammatory Disorders Research (18 papers). Markku Hakala collaborates with scholars based in Finland, United States and Canada. Markku Hakala's co-authors include Hannu Kautiainen, Pentti Nieminen, Marjatta Leirisalo‐Repo, Pekka Hannonen, Timo Möttönen, Markku Korpela, Kari Puolakka, Markku Kauppi, Leena Paimela and Raija K. Niemelä and has published in prestigious journals such as The Lancet, CHEST Journal and Annals of the Rheumatic Diseases.

In The Last Decade

Markku Hakala

102 papers receiving 2.8k citations

Peers

Markku Hakala

RHEUM

HEMAT

SURGE

EPIDE

IMMUN

Imad Uthman Lebanon

J. Dixey United Kingdom

J. M. W. Hazes Netherlands

Michel De Bandt France

Torkell Ellingsen Denmark

S Todesco Italy

Meral Çalgünerı Türkiye

F C Breedveld Netherlands

İhsan Ertenli Türkiye

J.C. Piette France

Imad Uthman Lebanon

Markku Hakala

1.6k ×0.9

RHEUM

671 ×1.0

HEMAT

556 ×1.1

SURGE

277 ×0.8

EPIDE

515 ×1.4

IMMUN

Citations per year, relative to Markku Hakala Markku Hakala (= 1×) peers Imad Uthman

Countries citing papers authored by Markku Hakala

Since Specialization

Citations

This map shows the geographic impact of Markku Hakala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markku Hakala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markku Hakala more than expected).

Fields of papers citing papers by Markku Hakala

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markku Hakala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markku Hakala. The network helps show where Markku Hakala may publish in the future.

Co-authorship network of co-authors of Markku Hakala

This figure shows the co-authorship network connecting the top 25 collaborators of Markku Hakala. A scholar is included among the top collaborators of Markku Hakala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markku Hakala. Markku Hakala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hakala, Markku, Heikki Kröger, Heikki Valleala, et al.. (2012). Once-monthly oral ibandronate provides significant improvement in bone mineral density in postmenopausal women treated with glucocorticoids for inflammatory rheumatic diseases: a 12-month, randomized, double-blind, placebo-controlled trial. Scandinavian Journal of Rheumatology. 41(4). 260–266. 40 indexed citations

Immonen, Kai, Patrik Finne, Carola Grönhagen‐Riska, et al.. (2011). A marked decline in the incidence of renal replacement therapy for amyloidosis associated with inflammatory rheumatic diseases – data from nationwide registries in Finland. Amyloid. 18(1). 25–28. 41 indexed citations

Immonen, Kai, Tom Pettersson, Patrik Finne, et al.. (2011). Decline in the incidence of renal failure due to amyloidosis associated with inflammatory rheumatic diseases. Amyloid. 18(sup1). 229–230. 3 indexed citations

Dijkmans, Ben A. C., Paul Emery, Markku Hakala, et al.. (2009). Etanercept in the Longterm Treatment of Patients With Ankylosing Spondylitis. The Journal of Rheumatology. 36(6). 1256–1264. 51 indexed citations

Hakala, Markku, Juha Risteli, Hannu Kautiainen, et al.. (2008). Combination drug strategy in recent‐onset rheumatoid arthritis suppresses collagen I degradation and is associated with retardation of radiological progression. Scandinavian Journal of Rheumatology. 37(2). 90–93. 6 indexed citations

Takalo, R., Airi Jartti, Raija K. Niemelä, et al.. (2006). Bone oedema predicts erosive progression on wrist MRI in early RA--a 2-yr observational MRI and NC scintigraphy study. Lara D. Veeken. 45(12). 1542–1548. 77 indexed citations

Hakala, Markku, et al.. (2006). Osteolysis after Sutter metacarpophalangeal arthroplasty: A prospective study of 282 implants followed up for 5.7 years. Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery. 40(5). 297–301. 5 indexed citations

Belt, Eero A., et al.. (2005). Comparison of Swanson and Sutter Metacarpophalangeal Arthroplasties in Patients With Rheumatoid Arthritis: A Prospective and Randomized Trial. The Journal Of Hand Surgery. 30(6). 1276–1281. 13 indexed citations

Haapasaari, Jarkko, et al.. (2003). Good results from combining etanercept to prevailing DMARD therapy in refractory juvenile idiopathic arthritis.. PubMed. 20(6). 867–70. 19 indexed citations

10.

P��kk�, E., et al.. (2001). Magnetic resonance imaging and magnetic resonance sialography of parotid glands in primary Sj�gren's syndrome. Arthritis & Rheumatism. 45(6). 512–518. 46 indexed citations

11.

Niemelä, Raija K., Sirkku M. Pikkujämsä, Markku Hakala, Heikki V. Huikuri, & Juhani Airaksinen. (2000). No signs of autonomic nervous system dysfunction in primary Sjörgen's syndrome evaluated by 24 hour heart rate variability.. PubMed. 27(11). 2605–10. 14 indexed citations

12.

Söderlin, Maria K., Esko Alasaarela, & Markku Hakala. (1999). Reactive Arthritis Induced by Clostridium Difficile Enteritis as a Complication of Helicobacter Pylori Eradication. Clinical Rheumatology. 18(4). 337–338. 9 indexed citations

13.

Risteli, Juha, Reijo Luukkainen, Leila Risteli, et al.. (1999). The value of synovial fluid analysis in the assessment of knee joint destruction in arthritis in a three year follow up study. Annals of the Rheumatic Diseases. 58(9). 559–562. 14 indexed citations

14.

Hakala, Markku, et al.. (1997). HLA Markers in a Community-based Rheumatoid Arthritis Series. Annals of Medicine. 29(4). 291–296. 14 indexed citations

15.

Ritvaniemi, Pertti, Jarmo Körkkö, Jacky Bonaventure, et al.. (1995). Identification of col2a1 gene mutations in patients with chondrodysplasias and familial osteoarthritis. Arthritis & Rheumatism. 38(7). 999–1004. 50 indexed citations

16.

Kauppi, Markku & Markku Hakala. (1994). Prevalence of Cervical Spine Subluxations and Dislocations in a Community-based Rheumatoid Arthritis Population. Scandinavian Journal of Rheumatology. 23(3). 133–136. 50 indexed citations

17.

Forsberg, S, et al.. (1993). More Evidence of Distinctive Features of Mixed Connective Tissue Disease. Scandinavian Journal of Rheumatology. 22(2). 63–68. 26 indexed citations

18.

Timonen, T., Markku Hakala, & Hannu Syrjälä. (1992). Serious Reversible Thrombotic Complications of Thrombocytosis in Myeloid Leukaemia. Platelets. 3(1). 53–55. 2 indexed citations

19.

Ilonen, Jorma, Markku Hakala, Helena Reijonen, & A Tiilikainen. (1991). B27-bearing HLA haplotypes in rheumatoid arthritis: Characterization in finnish patients. Human Immunology. 30(1). 7–10. 13 indexed citations

20.

Hakala, Markku, et al.. (1986). Diffuse Interstitial Lung Disease in Rheumatoid Arthritis: Views on Immunological and HLA Findings. Scandinavian Journal of Rheumatology. 15(4). 368–376. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact